Diabetes

This hub delivers an in-depth, evidence-based exploration of diabetes mellitus, uniting authoritative articles on disease mechanisms, diagnosis, management, and prevention. Covering both type 1 and type 2 diabetes, as well as rare and secondary forms, this collection provides readers with comprehensive information on risk factors, clinical presentation, complications, and the latest advances in research and technology. Topics include the impact of nutrition and lifestyle, pharmacological and non-pharmacological therapies, monitoring strategies, acute and chronic complications, and innovative developments such as artificial pancreas systems and digital health tools. These resources also examine the psychosocial aspects of living with diabetes and offer practical guidance for both patients and healthcare professionals. Whether you seek foundational knowledge or current developments in diabetes care, this hub serves as a trusted, up-to-date reference.

Okra and Diabetes: What Research Says About Its Blood Sugar Control Effects

Emerging evidence from clinical and mechanistic studies reveals how okra’s natural compounds lower blood sugar, balance lipids, and support overall metabolic health in diabetes.

Alcohol and Diabetes

Diabetes Screening

Does the Keto Diet Increase the Risk of Diabetes?

Diabetic Coma Severe Hypoglycemia

Diabetes Diagnosis

Walking After Meals: Small Habit, Big Metabolic Gains

What is Diabetic Retinopathy?

The Risks of Prediabetes

Risks to Infants of Diabetic Mothers

Adiponectin and Diabetes

Diabetic Mastopathy Diagnosis

See more featured articles »

Genetic Testing for Diabetes

Diabetic Neuropathy Treatments

Diabetes and Skin Problems

How Does Semaglutide Work to Lose Weight?

Is a Plant-Based Diet Good for Type 2 Diabetes?

What is Diabetic Ketoacidosis?

Harnessing the Power of AI: Predicting Diabetes Onset Before It Strikes

What is Diabetic Nephropathy?

Diabetic Emergencies: What to Do

Diabetic Foot Problems

Diabetes Symptoms

Diabetes Types

Diabetes and Sleep

Causes of Foot Pain

Diabetes and Mucormycosis

The Impact of Glucagon on Diabetes Management

Diabetic Neuropathy Pathogenesis

Diabetic Retinopathy Symptoms

What Causes Diabetes?

Diabetic Hypoglycemia Treatments

Diabetes and Periodontitis

What are Nightmares and Why Do They Occur?

Diabetic Coma Treatments

COVID-19 and Diabetes

Diabetes and Pregnancy

What is HbA1c?

Bionic Advancements: The Next Generation of Insulin Delivery Devices

Understanding MODY 5: A Rare Genetic Form of Diabetes

Advanced Diabetic Ketoacidosis

Diabetes and Wound Healing

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Diabetes in Men versus Women

Diabetes Risk Factors

Navigating Insulin Pumps: Technology, Benefits, and What’s Next

Animals That Can Detect Hypoglycemia

Diabetic Retinopathy Diagnosis

Vitamin D and Type 2 Diabetes

What is Diabetic Neuropathy?

Diabetic Hypoglycemia Etiology

The Future of Diabetes Treatment

Red Blood Cell Morphology Changes in Diabetes

Diabetic Ketoacidosis Causes

Pins and Needles and Diabetes

Diabetic Neuropathy Symptoms

How Baking Soda Affects People with Type 2 Diabetes

Diabetes in Men

Can I reverse my prediabetes naturally

What Causes Diabetic Nephropathy (Kidney Disease)?

Diabetic Nephropathy Symptoms

Are Low Carbohydrate Diets Good for Type 2 Diabetes?

What is a Diabetic Coma?

History of Diabetes

Cause of Diabetic Coma

Diabetes Management

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

Supplements for Diabetes

Diabetic Retinopathy Risk Factors

Diabetes Complications

Diabetes and Vision

Treatment and Prognosis for Diabetic Mastopathy

Diabetic Retinopathy Treatments

Research into a Cure for Diabetes

Diabetic Mastopathy: Complication of Diabetes Mellitus

What is Diabetes?

Diabetic Nephropathy Treatment

Diabetes Pathophysiology

Low Sugar Foods for Diabetes

Nonketotic Hyperosmolar Coma

Does the 'Stomach Flu' Vaccine Prevent Type I Diabetes?

Artificial Pancreas Systems: The Future of Diabetes Management?

Diabetic Neuropathy Diagnosis

What is HbA1C Testing?

What is Diabetic Hypoglycemia?

Encapsulating Islet Cells for the Treatment of Diabetes

How does Gestational Diabetes Affect the Baby?

Epigenetic Mechanisms in Type 2 Diabetes

Hypoglycemic Unawareness

Effects of Hyperglycemia on the Vascular System

Latest Diabetes News and Research

Bariatric surgery offers greater long-term health protection for seniors than GLP-1 drugs

Metabolic and bariatric surgery offers significantly greater long-term protection against heart attack, stroke and death than widely-used GLP-1 drugs in older adults with obesity and diabetes, according to new real-world analysis study presented today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.

6 May 2026

Bariatric surgery outperforms GLP-1 medications for obesity disease remission

Metabolic and bariatric surgery delivers significantly greater weight loss and higher rates of obesity-related disease remission than glucagon-like peptide-1 receptor agonists (GLP-1s), according to one of the largest and most comprehensive real-world comparisons of the two treatments.

6 May 2026

Six genes found to connect pancreatic cancer with metabolic dysfunction

New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain why people with metabolic disease often face poorer cancer outcomes and pointing to future ways to predict recurrence and develop more targeted treatments.

6 May 2026

App launched to track heart health after high-risk pregnancies

The MumCare app addresses postpartum cardiovascular risk, supporting women in managing health after pregnancy complications through personalized digital tools.

6 May 2026

Popular GLP-1 drugs significantly reduce major cardiovascular events,

Researchers evaluate the long-term cardiovascular safety and efficacy of GLP-1RAs in high-risk populations.

6 May 2026

Exercise remains essential alongside GLP-1 obesity treatments

As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in the Journal of the American Medical Association, or JAMA, underscores a persistent gap in care: integrating exercise into weight management in ways patients can sustain.

5 May 2026

Both low and high heart rates linked to stroke risk

A new study presented today at the European Stroke Organisation Conference (ESOC) 2026 suggests that both very low and very high resting heart rates are linked with an increased risk of stroke.

5 May 2026

Stroke incidence rises again with widening ethnic health inequalities

A new study presented today at the European Stroke Organisation Conference (ESOC) 2026 shows that after decades of decline, stroke incidence is rising again, driven by higher rates in some ethnic minority populations and concentrated among socioeconomically disadvantaged groups.

5 May 2026

AI creates detailed map of fat and muscle distribution to predict major health risks

Researchers used AI to analyze whole-body MRI scans from more than 66,000 participants to create the most detailed reference map to date of how fat and muscle are distributed in the human body across age, sex and height.

5 May 2026

U.S. bariatric surgery rates drop significantly amid GLP-1 surge

The number of metabolic and bariatric surgery procedures in the United States dropped below 200,000 in 2024 for the first time since 2020, a more than 20% decline from the prior year, according to new research presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

Bariatric surgery improves outcomes for patients with obesity and chronic kidney disease

Metabolic and bariatric surgery, also known as weight-loss surgery, dramatically improves outcomes for patients with obesity and chronic kidney disease (CKD), significantly reducing the risk of kidney failure, major cardiovascular events and death, according to new research presented here today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

GLP-1 use surges as surgery rates drop for severe obesity

Drawing on electronic health records from nearly 20 million patients with severe obesity, researchers from University of California San Diego find that GLP-1 prescriptions have grown exponentially -- from less than 4,600 prescriptions in 2018 to more than 1.4 million in 2025 -- according to a new real-world analysis presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

Bariatric surgery costs significantly less than GLP-1 drugs over two years

A new real-world analysis of more than 90,000 patients with obesity and type 2 diabetes finds metabolic and bariatric surgery is costs significantly less than weekly injections of GLP-1 drugs over a two-year period, according to a new research presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

Study links antimicrobial peptides to amyloid disease and neurodegeneration

For decades, antimicrobial peptides (AMPs) and amyloid-forming peptides were studied in largely separate contexts.

5 May 2026

Study reveals epigenetic adaptation of beta cells across lifespan and disease

As people age, most maintain normal blood sugar even as insulin resistance tends to rise. New research suggests that pancreatic beta cells help meet this demand through gradual epigenetic changes in regulatory regions of the genome that support beta-cell identity and function.

5 May 2026

GLP-1 drugs combined with surgery yield superior weight loss results

People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and bariatric surgery achieve substantially greater weight loss than with the medications alone, according to new research presented today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

AI-driven model predicts type 1 diabetes risk with greater accuracy

Researchers use machine learning and genetic analysis to uncover type 1 diabetes risk factors, improving prediction accuracy and identifying patient subtypes.

5 May 2026

A new tool that predicts obesity-related disease risk beyond BMI

OBSCORE is a data-driven tool that identifies high-risk individuals for obesity-related diseases, enhancing treatment targeting beyond traditional BMI metrics.

5 May 2026

Blood tests years before pregnancy predict risk of hypertension

Pre-pregnancy blood biomarkers linked to hypertension risk highlight the potential for early intervention in managing hypertensive disorders of pregnancy.

5 May 2026

Virginia Tech researcher wins NIH award to study metabolic brain health

Mary Elizabeth Baugh, a research scientist with Virginia Tech's Fralin Biomedical Research Institute at VTC, has been awarded a National Institutes of Health Mentored Research Scientist Development Award to study how metabolic health influences the brain systems that shape what and how we eat.

4 May 2026